These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9009444)

  • 1. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects.
    Iolascon A; D'Agostaro G; Perrotta S; Izzo P; Tavano R; Miraglia del Giudice B
    Haematologica; 1996; 81(6):543-59. PubMed ID: 9009444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and genetics of congenital dyserythropoietic anemias (CDA)].
    Rössler J; Havers W
    Klin Padiatr; 2000; 212(4):153-8. PubMed ID: 10994542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.
    Fukuda MN
    Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis.
    Heimpel H
    Ann Hematol; 2004 Oct; 83(10):613-21. PubMed ID: 15278299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygosity of CDAN II (HEMPAS) gene may be detected by the analysis of erythrocyte membrane glycoconjugates from healthy carriers.
    Zdebska E; Mendek-Czajkowska E; Ploski R; Woêniewicz B; Koscielak J
    Haematologica; 2002 Feb; 87(2):126-30. PubMed ID: 11836161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Localized gene of the rare "Norrland disease". CDA-III blood disease with dominant heredity].
    Sandström H; Wahlin A
    Lakartidningen; 1999 Jan; 96(4):343-7. PubMed ID: 10024825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital dyserythropoietic anemias.
    Marks PW; Mitus AJ
    Am J Hematol; 1996 Jan; 51(1):55-63. PubMed ID: 8571938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dyserythropoietic anemia associated with homozygous Hb Plasencia [α125(H8)Leu→Arg (α2)] (HBA2:c.377T>G), a variant with an unstable α chain.
    Garçon L; Iolascon A; Pissard S; Esposito MR; Russo R; Fenneteau O; Fénéant-Thibault M; Heimpel H; Delaunay J
    Hemoglobin; 2010; 34(6):576-81. PubMed ID: 21077766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital dyserythropoietic anemia type II: serologic and morphologic family study.
    Ricci P; Baccarani M; Biagini G; Preda P; Tomasini I; Zucchelli P; Tura S
    Nouv Rev Fr Hematol (1978); 1979; 21(2):197-207. PubMed ID: 514807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy.
    Goede JS; Benz R; Fehr J; Schwarz K; Heimpel H
    Ann Hematol; 2006 Sep; 85(9):591-5. PubMed ID: 16767397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the understanding of the congenital dyserythropoietic anaemias.
    Wickramasinghe SN; Wood WG
    Br J Haematol; 2005 Nov; 131(4):431-46. PubMed ID: 16281933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphological studies of erythrocytes in congenital dyserythropoietic anemia type II].
    Koehler M; Schmidt-Riese L; Brandeis WE
    Acta Haematol Pol; 1990; 21(2):144-52. PubMed ID: 2131714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital dyserythropoietic anemia type II: a case report and literature review].
    Li Y; Zhao X; Zhou K; Li Y; Li JP; Ye L; Peng GX; Fan HH; Jing LP; Zhang L; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):270-3. PubMed ID: 22781715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital dyserythropoietic anemia type III.
    Sandström H; Wahlin A
    Haematologica; 2000 Jul; 85(7):753-7. PubMed ID: 10897128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Congenital dyserythropoietic anemia type II (HEMPAS)].
    Fukuda MN
    Tanpakushitsu Kakusan Koso; 1992 Aug; 37(11 Suppl):1929-34. PubMed ID: 1410484
    [No Abstract]   [Full Text] [Related]  

  • 16. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene.
    Bianchi P; Fermo E; Vercellati C; Boschetti C; Barcellini W; Iurlo A; Marcello AP; Righetti PG; Zanella A
    Hum Mutat; 2009 Sep; 30(9):1292-8. PubMed ID: 19621418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycophorin A in two patients with congenital dyserythropoietic anemia type I and type II is partly unglycosylated.
    Zdebska E; Adamczyk-Popławska M; Kościelak J
    Acta Biochim Pol; 2000; 47(3):773-9. PubMed ID: 11310976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of erythrocyte glycoconjugates are identical in two families with congenital dyserythropoietic anemia type II with different chromosomal localizations of the disease gene.
    Zdebska E; Iolascon A; Spychalska J; Perrotta S; Lanzara C; Smolenska-Sym G; Koscielak J
    Haematologica; 2007 Mar; 92(3):427-8. PubMed ID: 17339199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia type II (CDA-II).
    Iolascon A; Miraglia del Giudice E; Perrotta S; Granatiero M; Zelante L; Gasparini P
    Blood; 1997 Nov; 90(10):4197-200. PubMed ID: 9354691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Favorable effect of splenectomy on anemia in 3 siblings with type II congenital dyserythropoietic anemia (HEMPAS). (Ultrastructural changes in erythrocytes after splenectomy)].
    Chrobák L; Spacek J
    Vnitr Lek; 1997 Oct; 43(10):635-8. PubMed ID: 9601875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.